Altshuler Shaham LTD Cellectis S.A. Transaction History

Altshuler Shaham LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$15.53 - $19.75 $614,801 - $781,863	-39,588 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$15.58 - $28.41 $1,744 - $3,181	-112 Reduced 0.28%	39,588 $659,000
Q3 2018 Nov 13, 2018	BUY	$25.99 - $30.6 $1.03 Million - $1.21 Million	39,700 New	39,700 $1.12 Million

9.73M

30.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $101M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.